| Systematic review of colchicine neuromyopathy: risk factors, duration and resolution T McEwan, J Bhambra, DF Liew, PC Robinson Seminars in Arthritis and Rheumatism, 152150, 2022 | 5 | 2022 |
| Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees JJ Tsakas, DFL Liew, CL Adams, CL Hill, S Proudman, S Whittle, ... BMC rheumatology 6 (1), 1-8, 2022 | | 2022 |
| Prevalence, risk factors, and outcomes of gout flare in patients hospitalized for PCR-confirmed COVID-19: A multicenter retrospective cohort study K Jatuworapruk, P Satpanich, PC Robinson, R Grainger The Journal of Rheumatology, 2022 | 1 | 2022 |
| Rheumatic disease activity, glucocorticoid use and COVID-19. Response to:'Correspondence on'Characteristics associated with hospitalisation for COVID-19 in people with … KL Hyrich, M Gianfrancesco, PM Machado, J Yazdany, PC Robinson ANNALS OF THE RHEUMATIC DISEASES 81 (11), 2022 | | 2022 |
| Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry K Jatuworapruk, A Montgomery, M Gianfrancesco, R Conway, L Durcan, ... ACR Open Rheumatology 4 (11), 948-953, 2022 | 10 | 2022 |
| Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomes DFL Liew, PC Robinson The Lancet Rheumatology 4 (11), e743-e745, 2022 | 2 | 2022 |
| Rheumatic disease activity, glucocorticoid use and COVID-19. Response to:‘Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with … KL Hyrich, M Gianfrancesco, PM Machado, J Yazdany, PC Robinson Annals of the Rheumatic Diseases 81 (11), e223-e223, 2022 | 2 | 2022 |
| Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus (SLE) Patients from the United States: Data from the COVID‐19 Global Rheumatology Alliance MF Ugarte‐Gil, GS Alarcón, AM Seet, Z Izadi, AD Montgomery, ... Arthritis Care & Research, 2022 | | 2022 |
| Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry Z Izadi, MA Gianfrancesco, A Aguirre, A Strangfeld, EF Mateus, KL Hyrich, ... ACR open rheumatology 4 (10), 872-882, 2022 | 8 | 2022 |
| COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to:‘Correspondence on ‘Characteristics associated with … M Gianfrancesco, KL Hyrich, J Yazdany, PM Machado, PC Robinson Annals of the Rheumatic Diseases 81 (10), e191-e191, 2022 | 7 | 2022 |
| Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review IE van der Horst-Bruinsma, PC Robinson, EG Favalli, FD Verbraak, M Kim, ... Rheumatology and Therapy, 1-17, 2022 | 4 | 2022 |
| Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status S Maguire, S Al-Emadi, P Alba, MC Aguiar, TA Lawati, G Alle, B Bermas, ... Rheumatology, 2022 | 4 | 2022 |
| COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort C McMaster, DFL Liew, S Lester, A Rischin, RJ Black, V Chand, ... Rheumatology, 2022 | 5 | 2022 |
| Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey M DiIorio, K Kennedy, JW Liew, MS Putman, E Sirotich, SE Sattui, ... RMD open 8 (2), e002587, 2022 | 27 | 2022 |
| Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry SA Yeoh, M Gianfrancesco, S Lawson-Tovey, KL Hyrich, A Strangfeld, ... RMD Open 8 (2), e002508, 2022 | 13 | 2022 |
| Examining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review BL Sim, BZ Sim, M Tunbridge, DFL Liew, PC Robinson The Journal of Rheumatology, 2022 | 3 | 2022 |
| Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study Z Izadi, MA Gianfrancesco, G Schmajuk, L Jacobsohn, P Katz, S Rush, ... The Lancet Rheumatology 4 (9), e603-e613, 2022 | 13 | 2022 |
| Minimal Impact of the COVID‐19 Pandemic on Disease Activity and Health‐Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory … PC Robinson, PM Machado, N Haroon, LS Gensler, JD Reveille, V Taieb, ... ACR open rheumatology 4 (9), 819-824, 2022 | | 2022 |
| Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study PC Robinson, WP Maksymowych, LS Gensler, S Hall, M Rudwaleit, ... ACR Open Rheumatology 4 (9), 794-801, 2022 | 2 | 2022 |
| Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case–control analysis from the UK Biobank R Topless, R Green, SL Morgan, P Robinson, T Merriman, AL Gaffo BMJ open 12 (8), e062945, 2022 | 8 | 2022 |
Jinoos YazdanyUCSF在 ucsf.edu 的电子邮件经过验证
